Bellevue Group AG Acquires Shares of 109,117 Guardant Health Inc (GH)

Share on StockTwits

Bellevue Group AG acquired a new position in shares of Guardant Health Inc (NASDAQ:GH) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 109,117 shares of the company’s stock, valued at approximately $4,102,000.

Other large investors have also added to or reduced their stakes in the company. Benjamin F. Edwards & Company Inc. bought a new position in Guardant Health during the 4th quarter valued at about $26,000. Citigroup Inc. bought a new position in Guardant Health during the 4th quarter valued at about $94,000. Victory Capital Management Inc. bought a new position in Guardant Health during the 4th quarter valued at about $124,000. Pendal Group Ltd bought a new position in Guardant Health during the 4th quarter valued at about $213,000. Finally, Janney Montgomery Scott LLC bought a new position in Guardant Health during the 4th quarter valued at about $220,000. 5.81% of the stock is owned by institutional investors.

GH opened at $67.04 on Wednesday. Guardant Health Inc has a 1-year low of $27.04 and a 1-year high of $74.47.

Separately, Bank of America reissued a “neutral” rating and set a $60.00 price target (up from $42.00) on shares of Guardant Health in a report on Thursday, February 28th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $51.00.

ILLEGAL ACTIVITY NOTICE: This report was published by Zolmax and is the property of of Zolmax. If you are accessing this report on another domain, it was stolen and republished in violation of U.S. & international trademark and copyright laws. The original version of this report can be read at https://zolmax.com/investing/bellevue-group-ag-acquires-shares-of-109117-guardant-health-inc-gh/2941800.html.

Guardant Health Company Profile

Guardant Health, Inc, a precision oncology company, provides non-invasive cancer diagnostics. It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA.

Recommended Story: Special Dividends

Want to see what other hedge funds are holding GH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Guardant Health Inc (NASDAQ:GH).

Institutional Ownership by Quarter for Guardant Health (NASDAQ:GH)

Receive News & Ratings for Guardant Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardant Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

$164.87 Million in Sales Expected for GasLog Ltd  This Quarter
$164.87 Million in Sales Expected for GasLog Ltd This Quarter
Zacks: Analysts Anticipate Pioneer Natural Resources  Will Announce Earnings of $1.60 Per Share
Zacks: Analysts Anticipate Pioneer Natural Resources Will Announce Earnings of $1.60 Per Share
Investors Buy SPDR S&P Dividend ETF  on Weakness
Investors Buy SPDR S&P Dividend ETF on Weakness
Pensare Acquisition  Hits New 52-Week High at $10.26
Pensare Acquisition Hits New 52-Week High at $10.26
ChatCoin Market Cap Reaches $2.36 Million
ChatCoin Market Cap Reaches $2.36 Million
YEED  Market Cap Tops $0.00
YEED Market Cap Tops $0.00


Leave a Reply

 
© 2006-2019 Zolmax.